TSH/FT3/FT4 Rapid Quantitative Test (Fluorescence Immunoassay)

Clinical Significance:

1. TSH - A Sensitive Indicator of Thyroid Function

TSH is secreted by the pituitary and regulated by negative feedback from FT3 and FT4.

Changes in TSH occur more rapidly and significantly than changes in FT3/FT4, making it a highly sensitive marker for assessing the hypothalamic‑pituitary‑thyroid axis.

Particularly valuable for diagnosing subclinical hyperthyroidism and subclinical hypothyroidism, where FT3/FT4 may still be within normal ranges.

2. Clinical Utility in Disease Differentiation

Increased TSH is seen in: primary hypothyroidism, thyroid hormone resistance syndrome, ectopic TSH syndrome, TSH‑secreting tumors, and certain drug effects (dopamine antagonists, iodine‑containing drugs).

Decreased TSH is seen in: hyperthyroidism, subclinical hyperthyroidism, prolactinoma, hypercortisolism, acromegaly, and excessive use of glucocorticoids or antithyroid drugs.

Measuring TSH helps distinguish primary hypothyroidism (high TSH) from secondary/tertiary hypothyroidism (low or inappropriately normal TSH), which is often difficult based on clinical presentation alone.

3. FT3 and FT4-Direct Markers of Thyroid Function

FT3 and FT4 are the free, physiologically active forms of thyroid hormones, unaffected by changes in thyroid hormone‑binding proteins.

They directly reflect functional thyroid status and offer higher sensitivity and specificity than total T3/T4 (TT3/TT4).

Combined with TSH, they provide the most intuitive assessment of thyroid function.

4. Synergistic Clinical Application

The three‑marker panel (TSH, FT3, FT4) is the standard for evaluating thyroid disorders, including:

Diagnosis and monitoring of hyperthyroidism and hypothyroidism

Detection of subclinical thyroid dysfunction

Differentiation between primary and central (pituitary/hypothalamic) causes of thyroid disease

Monitoring response to antithyroid or thyroid hormone replacement therapyh test).